newsfilter
← Latest News
GlobeNewswire·

Chinook Therapeutics Announces Proposed Public Offering

SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ:KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that it has commence